Upload
usama-husham
View
229
Download
0
Embed Size (px)
Citation preview
8/12/2019 Nephrotic $ Case Study
1/30
(A study in pediatric department
8/12/2019 Nephrotic $ Case Study
2/30
...
) ( ...... ... ...
....
... ............ ...
...... ... ... ...
.....
8/12/2019 Nephrotic $ Case Study
3/30
...
.
...
... ... ..
8/12/2019 Nephrotic $ Case Study
4/30
((
((
7 (
8/12/2019 Nephrotic $ Case Study
5/30
Abstract:Background:
Children with nephrotic syndrome may have one or more relapse. These are diagnosed i
there is +++ or ++++ proteinuria for 3 or more days. Urine should be checked initially
twice weekly, then weekly after the first episode, and the families instructed to get i
contact should a relapse of proteinuria occur, or if there is ++ for more than 1 week. The objective of this study was to identify predictors of relapse and determine th
predictive score for relapse. Ninety-nine children with nephrotic syndrome visiting thpediatric nephrology outpatient clinic in Al- Kadhmia teaching hospital from 2010 to 201
were studied. This study was retrospective study. According to age ,5% ofpatients wer
N.S. less than 1 year , 17.5 % of patients were N.S. between 1-5 years & 77.5 % o
patients were N.S. equal or above 5 years. Regarding gender, 62.5 % patients wer
males while 37.5 % were females. Regarding relapses, 55 % of the patients ha
frequent relapse while 45 % of the patients had infrequent relapse. 65 % of th
patients were steroid sensitive, 35 % of the patients steroid resistant. In this study th
majority of patients were equal or more than 5 years, male, living in rural area, withonset between 1-5 years, steroid responsive, frequent relapse, having a follow up
between 1-2 years & having MCD on renal biobsy
Aim of study:1-Study demographic characteristics in patients with N.S. regarding age, gender &
residency
2-Study the characteristics of N.S. in those children regarding onset of the disease frequency of relapses & type of N.S. according to steroid sensitivity
3-Study the duration of follow up in patients with N.S.4-Study renal biopsy findings in patients with N.S.5-Study the atypical features in patients with N.S.
8/12/2019 Nephrotic $ Case Study
6/30
Introduction:
Nephrotic Syndrome (NS) is a common childhood illness characterized by massiv
proteinuria, hyperlipidemia, hypoalbuminemia & edema. NS is a disease of relapse and it i
a major problem to manage the cases with frequent relapse. So it is very important to fin
out such children who are prone to develop frequent relapse
The observations that nephrotic syndrome, some was responsive to corticosteroids othernot and that its clinical course could be characterized by remission and relapse led t
several further observations that remain highly relevant to both the treatment and prognosi
of nephrotic syndrome today.
DEFINITIONS(1)
1. NEPHROTIC SYNDROME:
Oedema, serum albumin < 25 g/l, proteinuria > 40 mg/m2/hour or urine protein creatininratio > 200 mg/mmol.
2. REMISSION:
Urinary protein excretion < 4 mg/m2/hour or urine dipstix nil/trace for 3 consecutive days.
3. RELAPSE:
Urinary protein excretion > 40 mg/m2/hour or urine dipstix ++ or more for 3 consecutiv
days.
4. FREQUENT RELAPSES:
Two or more relapses within 6 months of initial response or four or more relapses within
any 12 month period.
5. STEROID DEPENDENCE:
Two consecutive relapses occurring during the period of steroid taper or within 14 days o
its cessation.
6. STEROID RESISTANCE:
Failure to achieve remission in spite of 4 weeks of standard prednisolone therapy
8/12/2019 Nephrotic $ Case Study
7/30
EPIDEMIOLOGY
The annual incidence of nephrotic syndrome in most countries in the Western Hemispher
is estimated to range from 2 to 7 new cases per 100,000 children(2,3,4)
and the prevalence i
about 16 cases per 100,000 children(4)
. There is a male preponderance among youn
children, at a ratio of 2:1 to females, although this gender disparity disappears by
adolescence, making the incidence in adolescents and adults equal among males and
females (5, 6, and 7). The incidence of nephrotic syndrome has been fairly stable over the las
30 years, but there are suggestions that the histopathologic patterns may be changing. Fo
example, reports from different parts of the world indicate an increasing occurrence of focasegmental glomerulosclerosis (FSGS) not only after adjusting for variations in renal biops
practices but also based on then generous assumption that all patients who did not have
renal biopsy had minimal change nephrotic syndrome (MCNS)(5, 6, and 7)
. The incidence an
the histologic pattern of nephrotic syndrome are also affected by geographic location an
ethnic origin.
In this same study the authors found that although only 11% of Hispanic and 18% oCaucasian patients with nephrotic syndrome had FSGS, 47% of African American children
had this less favorable diagnosis(6)
. Age also correlates with both the frequency opresentation and the biopsy fi ndings associated with nephrotic syndrome.
The most common age for presentation is 2 years, and 70% to 80% of cases occur in
children younger than 6(2, 3)
. To some extent age also predicts the histologic lesio
associated with nephrotic syndrome. Children diagnosed before age 6 represented 79.6% o
those with MCNS compared with 50% of those with FSGS and only 2.6% of those with
membranoproliferative glomerulonephritis (MPGN)(8)
. When these data were analyzed o
the basis of renal histology, the median ages at presentation were found to be 3 years foMCNS, 6 years for FSGS, and 10 years for MPGN
(8). Thus excluding the fi rst year of life
these data combined suggest that the likelihood of having MCNS decreases with increasin
age, whereas the likelihood of having the less favorable diagnosis of FSGS or MPGN
increases(8, 9)
.
The histologic lesion associated with nephrotic syndrome has important ramifications fo
the likelihood of response to steroid treatment. Although almost 80% of children diagnose
with nephrotic syndrome in a multicenter International Study of Kidney Diseases i
Children (ISKDC) study entered remission following an initial 8-week course usin
prednisone, when these children were analyzed based on histology, steroid responsiveneswas found in 93% of those with MCNS compared with only 30% of those with FSGS an
7% of those with MPGN(8, 10)
. In addition to histology, response to steroids also varies wit
geographic location and ethnicity. Whereas 80% of children in western countries will b
steroid responsive, studies from South Africa, Nigeria, and more recently Ghana show tha
only 9% to 50% of children with nephrotic syndrome are steroid responsive(11,12,13)
. Failur
to respond to steroid treatment has important ramifications for the risk of developin
progressive renal failure later in life. In a multicenter evaluation of 75 children with FSGS
8/12/2019 Nephrotic $ Case Study
8/30
it was found that within 5 years after diagnosis, 21% had developed ESRD, 23% had
developed CKD, and 37% had developed persistent proteinuria, whereas only 11%
remained in remission (14)
. Thus once a child is given the diagnosis of FSGS, the risk fo
development of CKD or ESRD within 5 years is almost 50%.
ETIOLOGY
Nephrotic syndrome in childhood is largely primary or idiopathic, although a smal
proportion of cases are secondary to infectious agents and other glomerular and systemi
diseases. The etiology of nephrotic syndrome is also age dependent. Most cases appearin
in the first 3 months of life are referred to as congenital nephrotic syndrome (CNS) and ardue to genetic diseases. Although there has been no systematic study of the etiology o
nephrotic syndrome presenting in the rest of the first year of life (3 to 12 months), there ar
data suggesting that up to 40% of cases during this time may also be due to genetic cause(15)
. Beyond the first year of life and in the first decade, most cases are due to primary o
idiopathic nephrotic syndrome, whereas the proportion of secondary nephrotic syndrom
cases increases beyond the first 10 years of life (figure 1).
8/12/2019 Nephrotic $ Case Study
9/30
Figure 1: Etiology of Nephrotic syndrome (16)
8/12/2019 Nephrotic $ Case Study
10/30
Pathophysiology of the Nephrotic Syndrome
In addition to excessive loss of protein in the urine, the hallmarks of the nephrotic
syndrome include depression of certain serum proteins, edema formation, and a rise in
serum lipids. Loss of protein in the urine is the basic defect, and the fall in serum protein
production of edema fluid and hyperlipidemia stem from it (Fig. 2). Hypoalbuminemia i
the nephrotic syndrome is owing to the combination of increased urinary loss and increased
catabolism of albumin, chiefly in the kidney(17)
. The liver reacts to the low serum albumi
levels by increasing albumin synthesis, but in the nephrotic syndrome, the response i
inadequate(17)
. The hypoalbuminemia then leads to both hyperlipidemia and edem
formation.
Figure 2: Pathophysiology of edema (16)
Hyperlipidemia in the nephrotic syndrome stems from several different mechanisms. Ahigher level of low-density lipoprotein (LDL) cholesterol is the principal alteration in th
lipid profile, with increases chiefly in very low density lipoproteins (VLDL) an
apolipoproteins B, C-II, and C-III(18,19,20,21)
. The increase in apolipoprotein B is probably
related to both hypoalbuminemia and changes in colloid oncotic pressure. The increase inLDL and VLDL is not related to increased synthesis. Rather, it is owing to decrease
catabolism secondary to decreased binding of lipoprotein lipase to endothelial cells(19,22)
, t
reduced clearance of VLDL, and to a decrease in the VLDL receptor. In addition, lecithin
8/12/2019 Nephrotic $ Case Study
11/30
cholesterol acyl-transferase is lost in the urine so that there is limited uptake of surplu
cholesterol (21). High-density lipoprotein (HDL) cholesterol shows little change so that th
LDL/HDL is increased. Triglycerides are thought to increase by augmented synthesis(23)
o
decreased catabolism(22)
. Lipoprotein a [Lp(a)] is increased by synthesis alone. Th
increased synthesis of fibrinogen, transferrin, albumin, and apoA-1 is regulate
transcriptionally(19)
.
Edema formation is the symptom of the nephrotic syndrome that usually brings the patien
to clinical attention. Two possible mechanisms of action may contribute to the productio
of edema. The classic mechanism, now known as the underfill hypothesis, may manifest in
patients with low plasma volume and is usually seen in children with MCD(24, 25)
. In thi
instance, hypovolemia is the primary stimulus driving the kidney to retain sodium andwater and eventually resulting in edema formation as the result of the Starling forces (Fig
3).
Figure 3: hypothesis of nephrotic syndrome
However, most patients with the nephrotic syndrome are either normovolemic o
hypervolemic. Thus, the overfill hypothesis was constructed. According to this theory
sodium retention by the kidney is primary. Sodium retention leads to increased bloovolume and results in increased blood pressure. These changes then lead to alterations in
the Starling forces, which result in edema. Several factors result in sodium retention. Th
fall in colloid osmotic pressure results in decreased Kf, causing decreased sodium filtration
Distal tubular injury causes resistance to atrial natriuretic peptide, resulting in decreasenatriuresis
(26). Chronic tubulointerstitial disease is associated with decreased GFR an
sodium retention(24)
. Recent studies have shown that albumin directly stimulates th
sodium hydrogen exchanger 3 (NHE3) in the proximal tubule with increased sodium
8/12/2019 Nephrotic $ Case Study
12/30
retention. Rostoker et al(27)
showed abnormal capillary permeability in patients with
nephrotic syndrome that resolved with steroid therapy. They proposed that a cytokine o
other vascular permeability factor might be responsible. In any case, such increased
vascular permeability could lead to edema.
History and Physical Examination
The clinical diagnosis of idiopathic nephrotic syndrome is often very simple. In a child wit
periorbital or generalized edema, the primary care physician can quickly make thi
diagnosis by documenting significant proteinuria with more than 2 albumin on urin
dipstick or a spot urine protein/ creatinine ratio greater than 2 mg/mg and serum albumin o
less than 2.5 g/dl. In addition, a careful history should exclude possible complications andidentify children with atypical presentations that might reflect other serious systemi
illnesses. It should include an evaluation of any abdominal distension, which is usually du
to ascites and sometimes edema of the anterior abdominal wall. Although severe distension
may be accompanied by abdominal discomfort, persistent abdominal pain may be due to
primary bacterial peritonitis (a potentially life-threatening complication), gut edema, o
relative gut ischemia due to hypoperfusion secondary to intravascular volume depletionOther causes of an acute abdomen should also be considered. A history of coughing o
breathing difficulties or both may indicate pleural effusion. Pulmonary edema, thougrarely found in idiopathic nephrotic children, should lead to consideration of secondary
causes of nephrotic syndrome that might cause significant intravascular fluid retention
Although a history of gross hematuria is unusual in nephrotic syndrome, microscopi
hematuria may be seen in up to 23% of patients with MCNS and in a higher percentage o
patients with other histologic variants(8)
. Severe intravascular volume depletion may caus
acute renal failure, and some children may present with oliguria or anuria. In such case
prompt intravascular volume repletion is important to correct prerenal acute renal failurand to prevent development of acute tubular necrosis. A history of possible systemi
symptoms including fevers, weight loss, night sweats, polyuria, polydipsia, hair loss, ora
ulcers, rashes, abdominal pain, and joint pain or swelling should also be elicited, becaus
they may be manifestations of systemic diseases such as systemic lupus erythematosus
Henoch-Schnlein purpura, or diabetes mellitus, which can all cause nephrotic syndrome
A medication history should also be taken in that medications such as NSAIDs, gold, and
penicillamine can also cause nephrotic syndrome. The history should exclude other cause
of generalized edema, such as chronic liver failure, heart failure, and malnutrition in area
of the world where clinical malnutrition is prevalent. Regarding physical examinationblood pressure should be carefully determined in nephrotic children; it can be either low
(due to intravascular volume depletion) or elevated (due to neurohumoral responses t
hypovolemia, intrinsic renal causes, or occasionally renal vein thrombosis). Hypertensio
has been reported in up to 21% of children 6 years and under with biopsy-confirme
MCNS, and may be present in up to 50% of children with other histologic types(8)
. A
careful examination of the abdomen should also be performed to exclude abdomina
tenderness or guarding that may be signs of bacterial peritonitis. In addition, extremitie
8/12/2019 Nephrotic $ Case Study
13/30
should be examined to exclude warmth, tenderness, or pain that may suggest venou
thrombosis. Finally, obtaining a detailed family history is also important, because som
causes of nephrotic syndrome are familial, as previously discussed.
Laboratory Evaluation
Diagnosis of nephrotic syndrome is confirmed by the triad of generalized edema
proteinuria, albuminuria (2on dipstick or urine protein/creatinine ratio 2 mg/mg), an
hypoalbuminemia (serum albumin
2.5 g/dl), although hypercholesterolemia is alscommonly present. In addition to documenting proteinuria, urinalysis with microscopy
should be carried out to look for hematuria and possible red blood cell casts. In patient
with a typical presentation, serum studies should include an evaluation of complete bloocount, electrolytes, blood urea nitrogen (BUN), creatinine, and albumin levels. For patient
at an older age at presentation or with atypical presentation, additional serum studies t
exclude secondary causes of nephrotic syndrome should include C3 and C4 complemenlevels; antinuclear antibody (ANA) and possibly anti-double-stranded DNA; HIV antibody
hepatitis A, B, and C serologies; and consideration of other viral serologies such as HIV
antibodies. Because immunosuppressive therapy is the mainstay of treatment for most caseof childhood nephrotic syndrome, many pediatric nephrologists recommend placing a PPD
(purified protein derivative) test to screen for occult tuberculosis before institutin
immunosuppression. This is particularly important in areas of the world where tuberculosi
is endemic and for recent immigrants from such regions. In addition, many nephrologist
obtain a varicella IgG titer before treatment to classify patients as varicella-naive ovaricella-immune, which can be of great aid when suspecting or confirming varicell
exposure in children who are immunocompromised during treatment. A varicella-naiv
patient receiving immunosuppressive treatment for nephrotic syndrome who is exposed t
varicella should be treated with varicella zoster immunoglobulin (VZIG) within 96 hours oexposure if possible
(28). This passive immunization can sometimes be lifesaving due to th
potential severity of a primary varicella infection in an immunocompromised host. Rena
ultrasound does not usually have a role in the evaluation of childhood nephrotic syndrome
However, in the setting of a nephrotic child who develops gross hematuriathrombocytopenia, or unexplained persistent hypertension, a renal ultrasound should b
considered to exclude possible development of renal vein thrombosis.
Renal Biopsy
More than 80% of children with idiopathic nephrotic syndrome will respond to steroitherapy by entering complete remission. Based on this statistic, an initial trial of 4 to
weeks of high-dose daily steroid therapy is usually prescribed in children under 10 beforconsidering renal biopsy. In general, renal biopsy is indicated only in the setting of atypica
features such as (1) age at onset (less than 1 year or more than 10), (2) SDNS or SRNS, (3
gross or persistent microscopic hematuria or presence of red cell casts, (4) abnorma
serologies, or (5) significant persistent renal failure. Due to the known nephrotoxicit
(interstitial fi brosis) of calcineurin inhibitors such as cyclosporine and tacrolimus, rena
8/12/2019 Nephrotic $ Case Study
14/30
biopsy is also indicated before initiation of these second-line or third-lin
immunosuppressive agents, as well as approximately every 2 years as long as use of thes
medications continues.
Risk factors for relapses:
Infection is an important cause of relapse in MCNS, prevention & treatment of which could
reduce proteinuria without necessity of steroid(3)
. An Upper Respiratory Tract Infectio
(URTI) or a febrile episode often precipitates a relapse; occasionally there is no obviou
cause1. Asymptomatic UTI might be an important and under diagnosed cause of relapse(5
Role of Tuberculosis in inducing relapse remain controversial10. Young age and low leveof serum protein at onset are independent risk for relapse
(4). Relapse within the first year i
a powerful independent predictor of subsequent relapse and relapse within first 6 months o
presentation is highly predictive of subsequent course(6)
.
8/12/2019 Nephrotic $ Case Study
15/30
COMPLICATIONS
8/12/2019 Nephrotic $ Case Study
16/30
MANAGEMENT(29)
MANAGEMENT OF THE OEDEMATOUS STATE.
Bed rest
This is not required and usually not practical unless the child has gross oedema.
B. Diet
A normal protein diet with adequate calories is recommended. Previou
recommendations of high protein diet had not been shown to improve serum albumin
concentration.
Salt intake should be reduced during the oedematous state.
Antibiotics.
Children with nephrotic syndrome are more prone to primary bacterial peritonitisProphylactic oral penicillin at doses of 125 mg BD or 250 mg BD depending on the siz
of the child is recommended during relapse particularly with gross oedema in view o
the lack of home albuminuria monitoring and long distance from the hospital.
Pneumococcal vaccine can be considered. However, it must be cautioned that th
vaccine does not cover all strains of pneumococci and some children with nephrotic
syndrome have been shown to be poor responders to this vaccine.
Hypovolaemia.
Children with nephrotic syndrome can present with hypovolemia, the manisfestations o
which include abdominal pain, cold peripheries, poor pulse volume, hypotension, andhaemoconcentration.
The treatment is to infuse salt poor albumin at 0.5 to 1.0 g/kg/dose over one to tw
hours. If salt poor albumin is not available, other volume expanders like 5% albumin
plasma protein derivatives or human plasma can be used.
Fluid restriction
This is not usually recommended except in chronic oedematous states.
8/12/2019 Nephrotic $ Case Study
17/30
Diuretics.
Diuretic therapy is not usually necessary in steroid responsive nephrotic syndrome but i
required should be used with caution as it can precipitate hypovolemia.Salt poor albumin of 20 - 25% concentration can be used in symptomatic grossly
oedematous states together with intravenous frusemide at 1-2 mg/kg to produce
diuresis. There is however, the danger of fluid overload with salt poor albumin infusion
and the childs urine output and blood pressure should be closely monitored.
Hypercholesterolaemia
There is insufficient evidence for a recommendation to be made as yet.
MANAGEMENT OF THE COMPLICATIONS OF NEPHROTIC SYNDROME
A.I nfections.Children with nephrotic syndrome are prone to infections particularly cellulitis &
primary peritonitis.
Should a child with nephrotic syndrome develop primary peritonitis, the antibiotic
recommended is parenteral penicillin and a third generation cephalosporin as it has bee
found that about half of primary peritonitis is due to Streptococcal pneumoniaeand th
other half to gram negative bacilli.
The parents and children should be advised and cautioned about contact with chickenpoxand measles, and if exposed should be treated like any immunocompromised child. I
varicella-zoster immunoglobulin (VZIG) is available, it should be given within 72 hour
after exposure to chickenpox. If VZIG is not available, some units recommend giving
single dose of intravenous immunoglobulin.
B.Immunisation.While the child is on corticosteroid treatment and within 6 weeks after its cessation, onl
killed vaccines may be safely be administered to the child. Live vaccines can b
administered 6 weeks after cessation of corticosteroid therapy
C.Acute renal failur eThis is a rare complication in children with steroid responsive nephrotic syndrome. Th
actual cause is not known although hypovolemia has been implicated. Intrarenal factor
have also been postulated to play a role.
8/12/2019 Nephrotic $ Case Study
18/30
D.ThrombosisThis complication if suspected should be thoroughly investigated and treated to preven
fatal complications.
Treatment consists of anticoagulation with the various anticoagulants available. Th
duration of anticoagulation required is still controversial.
E.Acute Adrenal CrisisThis may be seen in children who have been on long term corticosteroid therapy
(equivalent to 18 mg/m2 of cortisone daily) when they undergo situations of stress
Adequate cover with corticosteroids during these periods of stress is recommended to b
given in 3 divided doses.
CORTICOSTEROIDS IN NEPHROTIC SYNDROMEAt I ni tial diagnosis
A paediatrician should be consulted before initiation of therapy in a child with newly
diagnosed nephrotic syndrome
Corticosteroids was found to be effective in inducing remission of nephrotic syndrom
from the 1940s, and has since then been used as first line therapy in the treatment o
idiopathic nephrotic syndrome although no controlled trial was ever conducted about it
efficacy
Controversy lies in the dosage and duration of corticosteroids used at initial diagnosis of th
nephrotic syndrome. Various regimes of corticosteroids have been used. The two regime
discussed were the modified ISKDC regime; and the so called longer initial steroidinduction regime proposed and studied by Ueda et al
(30) and Ksiazek and Wysznska
(31
who showed a 2 year relapse free rate of 50% for the long initial prednisolone dose versu
27.3% for the modified ISKDC regime.
8/12/2019 Nephrotic $ Case Study
19/30
Modified ISKDC regime
Prednisolone dosage at:
60 mg/m2/day (maximum 80 mg/day) for 4 weeks 40 mg/m2/48 hours for 4 weeks only.
Long initial prednisolone regime:
Prednisolone dosage at:
60 mg/m2/day (maximum 80 mg/day) for 4 weeks 40 mg/m2/48 hours for 4 weeks. Reduced by 25% monthly over the next 4 monthsThe choice of using either regime was left to the individual attending paediatrician.
A child with nephrotic syndrome who fails to respond to an initial four week treatment with
corticosteroids should be referred to a paediatric nephrologist for a renal biopsy.
Relapse
The majority of children with idiopathic nephrotic syndrome will relapse(32, 33)
. A relapse i
defined by urine albumin excretion of > 40 mg/m2/hour or urine dipstix of 2+ or more for
consecutive days.
Treatment of relapse
Prednisolone at 60 mg/m2/day (maximum 80 mg) is to be given until remission defined a
urine dipstix is trace or nil for 3 consecutive days after which the prednisolone dose i
reduced to 40 mg/m2/48 hours for 4 weeks.
It has not been shown that giving more corticosteroids for treatment of relapses results in
longer period of remission.
Breakthrough proteinuria may occur with intercurrent infection and usually does not requir
corticosteroid therapy if the child has no oedema and remains well.
8/12/2019 Nephrotic $ Case Study
20/30
Frequent r elapses and steroid dependence
An initial responder who has 2 or more relapses within 6 months of initial response or 4 o
more relapses in any 12 month period is said to have frequent relapses.
Re-induction of any relapse with corticosteroids is as described in the section 3.4.2 on
relapse i.e. Prednisolone at 60 mg/m2/day (maximum 80 mg) until urine dipstix is nil/trac
for 3 consecutive days, after which the prednisolone dose is reduced to 40 mg/m2/48 hour
for 4 weeks .The prednisolone is now tapered instead of discontinued at the end of the re
induction regime. The rate of tapering depends on the patient and the paediatrician in
charge. The prednisolone is then kept on as low an alternate day dose as possible for 6
months. This low dose alternate day prednisolone should preferabley not exceed 0.
mg/kg/dose.
Should a child relapse while on low dose alternate day prednisolone, the child should be re
induced as for a relapse; the prednisolone is again tapered to low dose alternate da
prednisolone. Cyclophosphamide should be considered if the nephrotic syndrome is steroi
dependent and the child shows signs of steroid toxicity
CYCLOPHOSPHAMIDE
A renal biopsy is notneeded prior to cyclophosphamide therapy.
Cyclophosphamide therapy is indicated for the treatment of steroid dependent nephroti
syndrome with signs of steroid toxicity like stunting of growth, cataracts, striae, severcushingoid features and osteoporosis and should be started when the child is in remission
following induction with corticosteroids.
Various trials have shown the superiority of cyclophosphamide with prednisolone versu
prednisolone alone in maintaining prolonged remission.(33, 34)
Various dose and duration o
oral cyclophosphamide have been used. The report by APN (35)
demonstrated a 2 yea
remission rate of 67% for cyclophosphamide at 2 mg/kg/day for 12 weeks against 22% fo
8 weeks given for children with steroid dependent nephrotic syndrome. Ueda et al(36)
in later paper comparing the 8 week versus 12 week duration of cyclophosphamide however
showed no difference. Concern was expressed about the side effects of cyclophosphamid
particularly on the gonads.
A total cumulative dose of cyclophosphamide of 168 mg/kg was adopted for the treatmen
of steroid dependent nephrotic syndrome i.e. 2 mg/kg/day for 12 weeks or 3 mg/kg/day fo
8/12/2019 Nephrotic $ Case Study
21/30
8 weeks. While the child is on cyclophosphamide, prednisolone therapy which can b
further reduced and discontinued once the child completes the cyclophosphamide therap
and remains in remission. Regular fortnightly review with full blood counts and urinalysi
should be carried out while the child is on oral cyclophosphamide.
RELAPSES POSTCYCLOPHOSPHAMIDE
Relapses after a course of cyclophosphamide is treated as for relapses after the initia
diagnosis of nephrotic syndrome if the child does not exhibit any further signs of steroid
toxicity.
Should the relapse occur soon after a course of cyclophosphamide when the child is stil
steroid toxic, or the child again becomes steroid toxic after multiple relapses, then
paediatric nephrology opinion should be sought.
Options available here are not many but fortunately this group of patients make up only
about 10 20% of children with nephrotic syndrome. The available options availabl
include:
A second course of cyclophosphamide Cyclosporine can also be used on a very selective basis by paediatric nephrologists and
has been shown to maintain remission in 80% of these patients.
Levamisole
URINE ALBUM IN MONITORING
It is advocated that monitoring of urine albumin excretion be done regularly either at hom
with urinary dipstix or at the nearest health centre.
8/12/2019 Nephrotic $ Case Study
22/30
Diagram 1: Summery of treatment in children with nephrotic syndrome(16)
PROGNOSIS
The single most important prognostic factor for maintenance of long-term normal rena
function in nephrotic syndrome is the patients initial response to corticosteroids. Althougchildren who enter complete remission during an 8-week initial course of ora
corticosteroids have an excellent prognosis, the prognosis for those who fail to ente
remission is more guarded. Overall, close to 80% of newly diagnosed children treated wit
corticosteroids will achieve complete remission(10)
. Steroid responsiveness varies by rena
histologic type, with 93% of children with MCNS being steroid responsive compared with
8/12/2019 Nephrotic $ Case Study
23/30
56% with mesangial proliferative glomerulonephritis (IgM nephropathy in some centers)
30% with FSGS, 7% with MPGN, and 0% with membranous nephropathy.5 In addition, th
frequency of steroid responsiveness generally decreases with increasing age at presentation
Among children with SSNS, relapse is common. It is estimated that 70% of children with
nephrotic syndrome will experience one or more relapses. However, the frequency o
relapses decreases over time. A large study of children with MCNS reported a gradua
increase in the number of nonrelapsing patients over time, such that 8 years after diseas
onset 80% of children were relapse-free(35)
. In addition, 75% of those children with n
relapses in the first 6 months after treatment either had rare relapses or continued in
remission for their entire clinical course. Risk factors for frequent relapses or a steroid
dependent course have not been carefully studied, but the literature suggests that an age oless than 5 years at onset and a prolonged time to initial remission are possible risk factor(36, 37)
. More recently Tsai et al. reported a higher incidence of the DD (homozygou
deletion) genotype for the angiotensin converting enzyme (ACE) gene in SDNS and SRNS
children compared with SSNS children, suggesting a potential role for ACE in regulatin
clinical response to steroids(38)
. Initial steroid resistance clearly identifies a subset o
patients at high risk for progressive kidney disease. It is estimated that 40% to 50% ochildren with SRNS will progress to CKD or ESRD within 5 years of diagnosis, despit
aggressive immunosuppression. Among children with nephrotic syndrome due to FSGSwho progress to ESRD, renal transplantation can also pose serious challenges. Nephroti
syndrome recurs in the allograft in up to 30% of children with FSGS and leads to graft los
in about 50% of such patients(39)
. Among children with FSGS due toNPHS2 mutations, th
risk for recurrence has been controversial(40)
. The introduction of antibiotics and steroids in
treating nephrotic syndrome has led to a significant reduction in mortality, from 60% t
70% to less than 5%. In an ISKDC series of 521 children with nephrotic syndrome, 1
deaths were reported, resulting in a mortality rate of 1.9%(41)
. Of note, 9 of these 1children had either early relapses or SRNS and 6 (60%) died from infections, confirming
infection as an important cause of mortality in nephrotic syndrome. Nephrotic syndrome i
one of the most common forms of renal disease seen in children. Although the introductio
of antibiotics and refinement of immunosuppressive medications have greatly decrease
mortality and improved the quality of life for children with this disease, neither th
mechanism(s) of action nor the target cell for these therapies is known. In spite of this, th
prognosis for long-term maintenance of normal renal function is excellent unless complet
remission cannot be achieved. Hopefully our growing understanding of the pathobiology o
nephrotic syndrome will lead to development of more effective therapies in the future.
8/12/2019 Nephrotic $ Case Study
24/30
Patients & methods:
Data were collected from patients recording files
Study design: reterospective Period of study : from 1of march 20131 of May 2013 Place: Al- Kadhimia teaching hospital in pediatric nephrology clinic Number of patients: 40 Parameters : Age, Gender, Residency, duration of follow up , characteristics o
nephrotic syndrome , biopsy, atypical feature
Categorization: The patient categorized as follows:o Group 1: remissiono Group 2: relapse. The children with relapse were further grouped according
to clinical course as
o Group 3: steroid responders:
infrequent relapses (IFR) with 2 relapses in 6 months or 3 relapsesin a year frequent relapses (FRNS) with 2 relapses in 6months or 3 relapses
in a year
o Group 4: steroid nonresponders (SNR) comprising those who have notattained remission with 4 weeks of daily steroid therapy at 2 mg/kg/day.
Inclusion criteriaA.Children with nephrotic syndrome, aged 112 years, following up at our
hospital for at least 1 years
B.Children in remission to determine the occurrence of relapse or notC.Children in relapse to see if they were respond to steroid or not
Exclusion criteria:o Children who not complete thier follow up for at least 1 year in our hospital
8/12/2019 Nephrotic $ Case Study
25/30
Results: 40 children with nephrotic syndrome visiting the pediatric nephrologclinic, Al- kadhimia teaching hospital, were eligible for the study
o Regarding the distribution of patient with nephrotic syndrome accordingto age as in table 1 , 2 patients (5%) were N.S. less than 1 year ,
patient (17.5 %) were N.S. between 1-5 years & 31 patient (77.5 %) wer
N.S. equal or above 5 years.
o Regarding the Demographic data in patients with nephrotic syndrome as in table 2
25 (62.5 %) patients were males while 15 were females (37.5 %) 22 (55 %) of patients reside a rural area while 18 (45 %) o
patients reside an urban area
o Regarding the Characteristics of nephrotic syndrome: as in table 3 2 (5 %) of the patients had onset of N.S. within 1 year , 23 (57.
%) of the patients had onset of N.S. between 1- 5 years & 15 (37.
%) of the patients had onset of N.S. equal & above 5 years
2 (5 %) of the patients had frequent relapse while 38 (95 %) of thpatients had infrequent relapse
26 (65 %) of the patients were steroid sensitive , 14 (35 %) of thpatients steroid resistant
o Regarding the duration of follow up: as in table 4 6 (15 %) of the patients were followed for 1 year , 17 (42.5 %) o
the patients were followed for 1- 2 years , 13 (32.5 %) of th
patients were followed for 2- 4 years & 4 (10 %) of the patient
were followed for equal & above 4 years
o Regarding renal biopsy characteristics in 17 patients with nephroticsyndrome : as in table 5
12 (70.6 %) of the patients had MCD , 2 (11.8 %) of the patienthad FSGN & 3 (17.6 %) of the patients had MPGN
8/12/2019 Nephrotic $ Case Study
26/30
o Regarding atypical features in patients with nephrotic syndromein 40patients: as in table 6
10 (25 %) of the patients were hypertensive 7 (17.5 %) of the patients had a hematuria at initial diagnosis 8 (20 %) of the patients had a raised in blood urea 0 (0 %) of the patients had a raised in serum creatinine
Tables:
Table number (1) .. Distribution of patient with nephrotic syndrome according to
age group
age Number of patients (%)
< 1 2 5
1-5 7 17.5
5 31 77.5Total 40 100 %
Table number (2) .. Demographic data of patient with nephrotic syndrome
Number of patients (%)
Gender
25 62.5
15 37.5Residency
rural 22 55
urban 18 45
Total / each 40 100 %
Table number (3) .. Characteristics of nephrotic syndrome
Number of patients (%)
Onset of disease
< 1 2 5
1-5 23 57.5
5 15 37.5relapses
frequent 2 5
8/12/2019 Nephrotic $ Case Study
27/30
infrequent 38 95
Types of NS
sensitive 26 65
Resistant 14 35
Total / each 40 100 %
Table number (4) .. Duration of follow up
age Number of patients (%)
< 1 6 15
1-2 17 42.5
2-4 13 32.5
4 4 10Total 40 100 %
Table number (5) .. Renal biopsy characteristics in 17 patients with nephrotic
syndrome
biopsy Number of patients (%)
MCD 12 70.6
FSGN 2 11.8
MPGN 3 17.6
Total 17 100 %
Table number (6). Atypical features in patient with nephrotic syndromein 40patients
feature Number of patients (%)hypertension 10 25
hematuria 7 17.5
blood urea 8 20 serum creatinine 0 0
8/12/2019 Nephrotic $ Case Study
28/30
Discussion:
o In this study, the distribution of patient with nephrotic syndromaccording to age as in table 1, the majority (77.5 %) were N.S. equal o
above 5 years.
This study similar to other study were the majority of patien(67%) were between equal or above 5 years. (43)
o In this study, the Demographic data in patients with nephrotic syndrome as in table 2
(62.5 %) patients were males while were (37.5 %) females (55 %) of patients reside a rural area while (45 %) of patient
reside an urban area
Which is nearly similar to other study : (67.9 %) patients were males while were (32.1 %) female
(42)
(60 %) of patients reside a rural area while (40 %) opatients reside an urban area
(43)
o In this study, the Characteristics of nephrotic syndrome: as in table 3
(5 %) of the patients had onset of N.S. within 1 year , (57.5 %) othe patients had onset of N.S. between 1- 5 years & (37.5 %) o
the patients had onset of N.S. equal & above 5 years
(55 %) of the patients had frequent relapse while (45 %) of thpatients had infrequent relapse
(65 %) of the patients were steroid sensitive , (35 %) of thepatients steroid resistant
Which is nearly similar to other study :(43) (3 %) of the patients had onset of N.S. within 1 year , (6
%) of the patients had onset of N.S. between 1- 5 years &
(30 %) of the patients had onset of N.S. equal & above 5
years
(50 %) of the patients had frequent relapse while (50 %) othe patients had infrequent relapse
8/12/2019 Nephrotic $ Case Study
29/30
(70 %) of the patients were steroid sensitive , (30 %) of thpatients steroid resistant
o In this study, the duration of follow up: as in table 4 (15 %) of the patients were followed for 1 year , (42.5 %) of th
patients were followed for 1- 2 years , (32.5 %) of the patient
were followed for 2- 4 years & (10 %) of the patients werfollowed for equal & above 4 years
Which is nearly similar to other study :(42) (12 %) of the patients were followed for 1 year , (40 %) o
the patients were followed for 1- 2 years , (30 %) of th
patients were followed for 2- 4 years & (18 %) of th
patients were followed for equal & above 4 years
o In this study, renal biopsy characteristics in 17 patients with nephroticsyndrome : as in table 5
(70.6 %) of the patients had MCD , (11.8 %) of the patients haFSGN & (17.6 %) of the patients had MPGN
Which is differ to other study :(44) Minimal change disease (85%), mesangial proliferatio
(5%), and focal segmental glomerulosclerosis (10%).
o In this study, atypical features in patients with nephrotic syndromein 40patients: as in table 6
(25 %) of the patients were hypertensive (17.5 %) of the patients had a hematuria at initial diagnosis (20 %) of the patients had a raised in blood urea Which is nearly similar to other study :(43)
(22.5 %) of the patients were hypertensive (22.2 %) of the patients had a hematuria at initial diagnosis (30 %) of the patients had a raised in blood urea
8/12/2019 Nephrotic $ Case Study
30/30
Conclusions:
In this study the majority of patients were equal or more than 5 years, male, living inrural area, with onset between 1-5 years, steroid responsive, frequent relapse, having
follow up between 1-2 years & having MCD on renal biobsy